F. Shen

发表

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.

Zhenghong Yuan, P. Revill, S. Locarnini, 2018, Virology.

HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.

Zhan-qing Zhang, Xiaonan Zhang, Zhenghong Yuan, 2009, Molecular immunology.

Exosomes Exploit the Virus Entry Machinery and Pathway To Transmit Alpha Interferon-Induced Antiviral Activity

Zhenghong Yuan, Jia Liu, Jiahui Ding, 2018, Journal of Virology.

Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling

Mengji Lu, Jiming Zhang, Xiaonan Zhang, 2020, Hepatology.

Exosomes exploit the virus entry machinery and pathway to transmit IFN-α-induced antiviral activity

Zhenghong Yuan, Jia Liu, Jiahui Ding, 2018, bioRxiv.

Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen

Zhenghong Yuan, Lu Gao, Min Wu, 2018, Antimicrobial Agents and Chemotherapy.

Residues Asn118 and Glu119 of hepatitis B virus X protein are critical for HBx-mediated inhibition of RIG-I-MAVS signaling.

Zhenghong Yuan, F. Shen, Jieliang Chen, 2019, Virology.

Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.

Zhan-qing Zhang, Xiaonan Zhang, Zhenghong Yuan, 2008, Clinical immunology.

PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation

Jiangxia Liu, M. Levrero, Lei Yue, 2017, Hepatology.

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

F. García-Alcalde, J. Young, Zhiheng Xu, 2017, Scientific Reports.

Hepatitis B virus sensitivity to interferon‐α in hepatocytes is more associated with cellular interferon response than with viral genotype

Jiangxia Liu, Mengji Lu, Zhenghong Yuan, 2018, Hepatology.

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.

J. Wu, J. Young, Zheng Zhou, 2017, Journal of medicinal chemistry.

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.

J. Wu, Min Jiang, Zheng Zhou, 2016, Journal of medicinal chemistry.

Characterization of Nucleosome Positioning in Hepadnaviral Covalently Closed Circular DNA Minichromosomes

J. Wu, Wen-gang Yang, Shuiming Qian, 2012, Journal of Virology.

Characterization of Nucleosome Positioning in Hepadnaviral Covalently Closed Circular DNA Minichromosomes

Wen-gang Yang, Shuiming Qian, Jim Z Wu, 2012, Journal of Virology.

Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen

Zhenghong Yuan, Lu Gao, Min Wu, 2018, Antimicrobial Agents and Chemotherapy.